Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer

J Natl Cancer Inst. 2024 Aug 22:djae184. doi: 10.1093/jnci/djae184. Online ahead of print.
No abstract available

Publication types

  • Editorial
  • Comment